Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer

Severe thrombocytopenia is a rare adverse event of panitumumab. Here, we report the first patient with metastatic colorectal cancer who developed severe thrombocytopenia, diagnosed as panitumumab-associated drug-induced immune thrombocytopenia (DITP). A clinical diagnosis of DITP can be obtained by...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Oncol
Asıl Yazarlar: Takamizawa, Shigemasa, Shoji, Hirokazu, Hirano, Hidekazu, Izutsu, Koji, Yamamoto, Shun, Iwasa, Satoru, Honma, Yoshitaka, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Boku, Narikazu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983597/
https://ncbi.nlm.nih.gov/pubmed/33776687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000512821
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller